Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Arq. neuropsiquiatr ; 65(3b): 834-837, set. 2007. ilus
Article in English | LILACS | ID: lil-465190

ABSTRACT

The rosuvastatin inducing rhabdomyolysis in McArdle disease (MD) has not been reported to date. A 35-years-old man had exercise intolerance, muscular fatigue and cramps during physical activity since infancy. He presented severe rhabdomyolysis episode with seizure and coma after use of rosuvastatin. The investigation showed increased serum creatinekinase levels and the forearm ischemic exercise did not increased venous lactate. The muscle biopsy showed subsarcolemmal and central acummulation of glycogen and absence of the myophosphorylase enzyme. The statin induced myopathy is discussed and the danger of its use in MD is emphasized.


Rosuvastatina induzindo rabdomiólise na doença de McArdle (MD) não foi relatada até o momento. Descrevemos o caso de um homem de 35 anos que desde a infância apresentava sintomas de intolerância aos exercícios, fadiga muscular e cãibras durante o esforço físico, porém após o uso de rosuvastatina apresentou episódio de rabdomiólise com crises convulsivas e coma. A investigação mostrou creatinoquinase sérica elevada e teste do esforço isquêmico sem aumento no lactato venoso. A biópsia muscular revelou acúmulo central e subsarcolemal de glicogênio nas fibras e ausência da enzima miofosforilase. Discutimos as estatinas induzindo miopatia, enfatizando o risco do seu uso na MD.


Subject(s)
Adult , Humans , Male , Fluorobenzenes/adverse effects , Glycogen Storage Disease Type V/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Pyrimidines/adverse effects , Rhabdomyolysis/chemically induced , Sulfonamides/adverse effects , Fluorobenzenes/therapeutic use , Glycogen Storage Disease Type V/blood , Glycogen Storage Disease Type V/pathology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Pyrimidines/therapeutic use , Rhabdomyolysis/blood , Rhabdomyolysis/pathology , Sulfonamides/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL